The	O
nitroxyl	B:C0068882
donor	I:C0068882
Angeli's	O
salt	I:C0103301
ameliorates	O
Staphylococcus	O
aureus	I:C0038172
-	O
induced	O
septic	O
arthritis	I:C1692886
in	O
mice	O
.	O

The	O
nitroxyl	O
donor	I:C0068882
Angeli's	B:C0103301
salt	I:C0103301
ameliorates	O
Staphylococcus	O
aureus	I:C0038172
-	O
induced	O
septic	O
arthritis	I:C1692886
in	O
mice	O
.	O

The	O
nitroxyl	O
donor	I:C0068882
Angeli's	O
salt	I:C0103301
ameliorates	O
Staphylococcus	B:C0038172
aureus	I:C0038172
-	O
induced	O
septic	O
arthritis	I:C1692886
in	O
mice	O
.	O

The	O
nitroxyl	O
donor	I:C0068882
Angeli's	O
salt	I:C0103301
ameliorates	O
Staphylococcus	O
aureus	I:C0038172
-	O
induced	O
septic	B:C1692886
arthritis	I:C1692886
in	O
mice	O
.	O

The	O
nitroxyl	O
donor	I:C0068882
Angeli's	O
salt	I:C0103301
ameliorates	O
Staphylococcus	O
aureus	I:C0038172
-	O
induced	O
septic	O
arthritis	I:C1692886
in	O
mice	B:C0025929
.	O

Septic	B:C1692886
arthritis	I:C1692886
is	O
a	O
severe	O
and	O
rapidly	O
debilitating	I:C0008679
disease	I:C0008679
associated	O
with	O
severe	O
joint	I:C0003862
pain	I:C0003862
,	O
inflammation	O
and	O
oxidative	O
stress	I:C0242606
.	O

Septic	O
arthritis	I:C1692886
is	O
a	O
severe	O
and	O
rapidly	B:C0008679
debilitating	I:C0008679
disease	I:C0008679
associated	O
with	O
severe	O
joint	I:C0003862
pain	I:C0003862
,	O
inflammation	O
and	O
oxidative	O
stress	I:C0242606
.	O

Septic	O
arthritis	I:C1692886
is	O
a	O
severe	O
and	O
rapidly	O
debilitating	I:C0008679
disease	I:C0008679
associated	O
with	O
severe	B:C0003862
joint	I:C0003862
pain	I:C0003862
,	O
inflammation	O
and	O
oxidative	O
stress	I:C0242606
.	O

Septic	O
arthritis	I:C1692886
is	O
a	O
severe	O
and	O
rapidly	O
debilitating	I:C0008679
disease	I:C0008679
associated	O
with	O
severe	O
joint	I:C0003862
pain	I:C0003862
,	O
inflammation	B:C0021368
and	O
oxidative	O
stress	I:C0242606
.	O

Septic	O
arthritis	I:C1692886
is	O
a	O
severe	O
and	O
rapidly	O
debilitating	I:C0008679
disease	I:C0008679
associated	O
with	O
severe	O
joint	I:C0003862
pain	I:C0003862
,	O
inflammation	O
and	O
oxidative	B:C0242606
stress	I:C0242606
.	O

Nitroxyl	B:C0068882
(	O
HNO	O
)	O
has	O
become	O
a	O
nitrogen	O
oxide	I:C0028167
of	O
significant	O
interest	O
due	O
to	O
its	O
pharmacological	O
endpoints	O
that	O
are	O
potentially	O
favorable	O
for	O
treating	O
varied	O
diseases	O
.	O

Nitroxyl	O
(	O
HNO	B:C0068882
)	O
has	O
become	O
a	O
nitrogen	O
oxide	I:C0028167
of	O
significant	O
interest	O
due	O
to	O
its	O
pharmacological	O
endpoints	O
that	O
are	O
potentially	O
favorable	O
for	O
treating	O
varied	O
diseases	O
.	O

Nitroxyl	O
(	O
HNO	O
)	O
has	O
become	O
a	O
nitrogen	B:C0028167
oxide	I:C0028167
of	O
significant	O
interest	O
due	O
to	O
its	O
pharmacological	O
endpoints	O
that	O
are	O
potentially	O
favorable	O
for	O
treating	O
varied	O
diseases	O
.	O

Nitroxyl	O
(	O
HNO	O
)	O
has	O
become	O
a	O
nitrogen	O
oxide	I:C0028167
of	O
significant	O
interest	O
due	O
to	O
its	O
pharmacological	O
endpoints	O
that	O
are	O
potentially	O
favorable	O
for	O
treating	O
varied	O
diseases	B:C0012634
.	O

However	O
,	O
whether	O
HNO	B:C0068882
also	O
serves	O
as	O
a	O
treatment	O
to	O
septic	O
arthritis	I:C1692886
is	O
currently	O
unknown	O
.	O

However	O
,	O
whether	O
HNO	O
also	O
serves	O
as	O
a	O
treatment	O
to	O
septic	B:C1692886
arthritis	I:C1692886
is	O
currently	O
unknown	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effect	O
of	O
the	O
HNO	B:C0068882
donor	I:C0068882
,	O
Angeli	O
's	I:C0103301
salt	I:C0103301
(	O
Angeli	O
's	I:C0103301
salt	I:C0103301
)	O
,	O
in	O
the	O
outcome	O
of	O
chronic	O
Staphylococcus	O
aureus	I:C0038172
(	O
Staphylococcus	O
aureus	I:C0038172
)	O
-	O
induced	O
septic	O
arthritis	I:C1692886
in	O
mice	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effect	O
of	O
the	O
HNO	O
donor	I:C0068882
,	O
Angeli	B:C0103301
's	I:C0103301
salt	I:C0103301
(	O
Angeli	O
's	I:C0103301
salt	I:C0103301
)	O
,	O
in	O
the	O
outcome	O
of	O
chronic	O
Staphylococcus	O
aureus	I:C0038172
(	O
Staphylococcus	O
aureus	I:C0038172
)	O
-	O
induced	O
septic	O
arthritis	I:C1692886
in	O
mice	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effect	O
of	O
the	O
HNO	O
donor	I:C0068882
,	O
Angeli	O
's	I:C0103301
salt	I:C0103301
(	O
Angeli	B:C0103301
's	I:C0103301
salt	I:C0103301
)	O
,	O
in	O
the	O
outcome	O
of	O
chronic	O
Staphylococcus	O
aureus	I:C0038172
(	O
Staphylococcus	O
aureus	I:C0038172
)	O
-	O
induced	O
septic	O
arthritis	I:C1692886
in	O
mice	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effect	O
of	O
the	O
HNO	O
donor	I:C0068882
,	O
Angeli	O
's	I:C0103301
salt	I:C0103301
(	O
Angeli	O
's	I:C0103301
salt	I:C0103301
)	O
,	O
in	O
the	O
outcome	O
of	O
chronic	B:C0008679
Staphylococcus	O
aureus	I:C0038172
(	O
Staphylococcus	O
aureus	I:C0038172
)	O
-	O
induced	O
septic	O
arthritis	I:C1692886
in	O
mice	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effect	O
of	O
the	O
HNO	O
donor	I:C0068882
,	O
Angeli	O
's	I:C0103301
salt	I:C0103301
(	O
Angeli	O
's	I:C0103301
salt	I:C0103301
)	O
,	O
in	O
the	O
outcome	O
of	O
chronic	O
Staphylococcus	B:C0038172
aureus	I:C0038172
(	O
Staphylococcus	O
aureus	I:C0038172
)	O
-	O
induced	O
septic	O
arthritis	I:C1692886
in	O
mice	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effect	O
of	O
the	O
HNO	O
donor	I:C0068882
,	O
Angeli	O
's	I:C0103301
salt	I:C0103301
(	O
Angeli	O
's	I:C0103301
salt	I:C0103301
)	O
,	O
in	O
the	O
outcome	O
of	O
chronic	O
Staphylococcus	O
aureus	I:C0038172
(	O
Staphylococcus	B:C0038172
aureus	I:C0038172
)	O
-	O
induced	O
septic	O
arthritis	I:C1692886
in	O
mice	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effect	O
of	O
the	O
HNO	O
donor	I:C0068882
,	O
Angeli	O
's	I:C0103301
salt	I:C0103301
(	O
Angeli	O
's	I:C0103301
salt	I:C0103301
)	O
,	O
in	O
the	O
outcome	O
of	O
chronic	O
Staphylococcus	O
aureus	I:C0038172
(	O
Staphylococcus	O
aureus	I:C0038172
)	O
-	O
induced	O
septic	B:C1692886
arthritis	I:C1692886
in	O
mice	O
.	O

The	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
effect	O
of	O
the	O
HNO	O
donor	I:C0068882
,	O
Angeli	O
's	I:C0103301
salt	I:C0103301
(	O
Angeli	O
's	I:C0103301
salt	I:C0103301
)	O
,	O
in	O
the	O
outcome	O
of	O
chronic	O
Staphylococcus	O
aureus	I:C0038172
(	O
Staphylococcus	O
aureus	I:C0038172
)	O
-	O
induced	O
septic	O
arthritis	I:C1692886
in	O
mice	B:C0025929
.	O

Daily	O
treatment	O
with	O
Angeli's	B:C0103301
salt	I:C0103301
inhibited	O
mechanical	O
hyperalgesia	I:C0020429
and	O
inflammation	O
(	O
edema	O
,	O
leukocyte	O
migration	I:C1326500
,	O
cytokines	O
release	I:C0948245
and	O
NF	O
-	I:C1749855
κB	I:C1749855
activation	I:C1749855
,	O
and	O
oxidative	O
stress	I:C0242606
)	O
resulting	O
in	O
reduced	O
disease	O
severity	O
(	O
clinical	O
course	O
,	O
histopathological	O
changes	O
,	O
proteoglycan	O
levels	O
in	O
the	O
joints	O
,	O
and	O
osteoclastogenesis	O
)	O
.	O

Daily	O
treatment	O
with	O
Angeli's	O
salt	I:C0103301
inhibited	O
mechanical	B:C0020429
hyperalgesia	I:C0020429
and	O
inflammation	O
(	O
edema	O
,	O
leukocyte	O
migration	I:C1326500
,	O
cytokines	O
release	I:C0948245
and	O
NF	O
-	I:C1749855
κB	I:C1749855
activation	I:C1749855
,	O
and	O
oxidative	O
stress	I:C0242606
)	O
resulting	O
in	O
reduced	O
disease	O
severity	O
(	O
clinical	O
course	O
,	O
histopathological	O
changes	O
,	O
proteoglycan	O
levels	O
in	O
the	O
joints	O
,	O
and	O
osteoclastogenesis	O
)	O
.	O

Daily	O
treatment	O
with	O
Angeli's	O
salt	I:C0103301
inhibited	O
mechanical	O
hyperalgesia	I:C0020429
and	O
inflammation	B:C0021368
(	O
edema	O
,	O
leukocyte	O
migration	I:C1326500
,	O
cytokines	O
release	I:C0948245
and	O
NF	O
-	I:C1749855
κB	I:C1749855
activation	I:C1749855
,	O
and	O
oxidative	O
stress	I:C0242606
)	O
resulting	O
in	O
reduced	O
disease	O
severity	O
(	O
clinical	O
course	O
,	O
histopathological	O
changes	O
,	O
proteoglycan	O
levels	O
in	O
the	O
joints	O
,	O
and	O
osteoclastogenesis	O
)	O
.	O

Daily	O
treatment	O
with	O
Angeli's	O
salt	I:C0103301
inhibited	O
mechanical	O
hyperalgesia	I:C0020429
and	O
inflammation	O
(	O
edema	B:C0013604
,	O
leukocyte	O
migration	I:C1326500
,	O
cytokines	O
release	I:C0948245
and	O
NF	O
-	I:C1749855
κB	I:C1749855
activation	I:C1749855
,	O
and	O
oxidative	O
stress	I:C0242606
)	O
resulting	O
in	O
reduced	O
disease	O
severity	O
(	O
clinical	O
course	O
,	O
histopathological	O
changes	O
,	O
proteoglycan	O
levels	O
in	O
the	O
joints	O
,	O
and	O
osteoclastogenesis	O
)	O
.	O

Daily	O
treatment	O
with	O
Angeli's	O
salt	I:C0103301
inhibited	O
mechanical	O
hyperalgesia	I:C0020429
and	O
inflammation	O
(	O
edema	O
,	O
leukocyte	B:C1326500
migration	I:C1326500
,	O
cytokines	O
release	I:C0948245
and	O
NF	O
-	I:C1749855
κB	I:C1749855
activation	I:C1749855
,	O
and	O
oxidative	O
stress	I:C0242606
)	O
resulting	O
in	O
reduced	O
disease	O
severity	O
(	O
clinical	O
course	O
,	O
histopathological	O
changes	O
,	O
proteoglycan	O
levels	O
in	O
the	O
joints	O
,	O
and	O
osteoclastogenesis	O
)	O
.	O

Daily	O
treatment	O
with	O
Angeli's	O
salt	I:C0103301
inhibited	O
mechanical	O
hyperalgesia	I:C0020429
and	O
inflammation	O
(	O
edema	O
,	O
leukocyte	O
migration	I:C1326500
,	O
cytokines	B:C0948245
release	I:C0948245
and	O
NF	O
-	I:C1749855
κB	I:C1749855
activation	I:C1749855
,	O
and	O
oxidative	O
stress	I:C0242606
)	O
resulting	O
in	O
reduced	O
disease	O
severity	O
(	O
clinical	O
course	O
,	O
histopathological	O
changes	O
,	O
proteoglycan	O
levels	O
in	O
the	O
joints	O
,	O
and	O
osteoclastogenesis	O
)	O
.	O

Daily	O
treatment	O
with	O
Angeli's	O
salt	I:C0103301
inhibited	O
mechanical	O
hyperalgesia	I:C0020429
and	O
inflammation	O
(	O
edema	O
,	O
leukocyte	O
migration	I:C1326500
,	O
cytokines	O
release	I:C0948245
and	O
NF	B:C1749855
-	I:C1749855
κB	I:C1749855
activation	I:C1749855
,	O
and	O
oxidative	O
stress	I:C0242606
)	O
resulting	O
in	O
reduced	O
disease	O
severity	O
(	O
clinical	O
course	O
,	O
histopathological	O
changes	O
,	O
proteoglycan	O
levels	O
in	O
the	O
joints	O
,	O
and	O
osteoclastogenesis	O
)	O
.	O

Daily	O
treatment	O
with	O
Angeli's	O
salt	I:C0103301
inhibited	O
mechanical	O
hyperalgesia	I:C0020429
and	O
inflammation	O
(	O
edema	O
,	O
leukocyte	O
migration	I:C1326500
,	O
cytokines	O
release	I:C0948245
and	O
NF	O
-	I:C1749855
κB	I:C1749855
activation	I:C1749855
,	O
and	O
oxidative	B:C0242606
stress	I:C0242606
)	O
resulting	O
in	O
reduced	O
disease	O
severity	O
(	O
clinical	O
course	O
,	O
histopathological	O
changes	O
,	O
proteoglycan	O
levels	O
in	O
the	O
joints	O
,	O
and	O
osteoclastogenesis	O
)	O
.	O

Daily	O
treatment	O
with	O
Angeli's	O
salt	I:C0103301
inhibited	O
mechanical	O
hyperalgesia	I:C0020429
and	O
inflammation	O
(	O
edema	O
,	O
leukocyte	O
migration	I:C1326500
,	O
cytokines	O
release	I:C0948245
and	O
NF	O
-	I:C1749855
κB	I:C1749855
activation	I:C1749855
,	O
and	O
oxidative	O
stress	I:C0242606
)	O
resulting	O
in	O
reduced	O
disease	O
severity	O
(	O
clinical	O
course	O
,	O
histopathological	O
changes	O
,	O
proteoglycan	B:C0033692
levels	O
in	O
the	O
joints	O
,	O
and	O
osteoclastogenesis	O
)	O
.	O

Daily	O
treatment	O
with	O
Angeli's	O
salt	I:C0103301
inhibited	O
mechanical	O
hyperalgesia	I:C0020429
and	O
inflammation	O
(	O
edema	O
,	O
leukocyte	O
migration	I:C1326500
,	O
cytokines	O
release	I:C0948245
and	O
NF	O
-	I:C1749855
κB	I:C1749855
activation	I:C1749855
,	O
and	O
oxidative	O
stress	I:C0242606
)	O
resulting	O
in	O
reduced	O
disease	O
severity	O
(	O
clinical	O
course	O
,	O
histopathological	O
changes	O
,	O
proteoglycan	O
levels	O
in	O
the	O
joints	B:C0022417
,	O
and	O
osteoclastogenesis	O
)	O
.	O

Daily	O
treatment	O
with	O
Angeli's	O
salt	I:C0103301
inhibited	O
mechanical	O
hyperalgesia	I:C0020429
and	O
inflammation	O
(	O
edema	O
,	O
leukocyte	O
migration	I:C1326500
,	O
cytokines	O
release	I:C0948245
and	O
NF	O
-	I:C1749855
κB	I:C1749855
activation	I:C1749855
,	O
and	O
oxidative	O
stress	I:C0242606
)	O
resulting	O
in	O
reduced	O
disease	O
severity	O
(	O
clinical	O
course	O
,	O
histopathological	O
changes	O
,	O
proteoglycan	O
levels	O
in	O
the	O
joints	O
,	O
and	O
osteoclastogenesis	B:C4279953
)	O
.	O

In	O
addition	O
,	O
Angeli	B:C0103301
's	I:C0103301
salt	I:C0103301
decreased	O
the	O
number	O
of	O
Staphylococcus	O
aureus	I:C0038172
colony	O
forming	I:C0201036
unities	I:C0201036
in	O
synovial	O
tissue	I:C0224494
,	O
enhanced	O
the	O
bactericidal	O
effect	I:C0544570
of	O
macrophages	O
and	O
inhibited	O
the	O
worsening	O
of	O
systemic	O
inflammatory	I:C0242966
response	I:C0242966
(	O
leukocyte	O
counts	I:C0023508
in	O
the	O
lung	O
and	O
systemic	O
proinflammatory	O
cytokine	I:C4227660
concentration	I:C4227660
)	O
.	O

In	O
addition	O
,	O
Angeli	O
's	I:C0103301
salt	I:C0103301
decreased	O
the	O
number	O
of	O
Staphylococcus	B:C0038172
aureus	I:C0038172
colony	O
forming	I:C0201036
unities	I:C0201036
in	O
synovial	O
tissue	I:C0224494
,	O
enhanced	O
the	O
bactericidal	O
effect	I:C0544570
of	O
macrophages	O
and	O
inhibited	O
the	O
worsening	O
of	O
systemic	O
inflammatory	I:C0242966
response	I:C0242966
(	O
leukocyte	O
counts	I:C0023508
in	O
the	O
lung	O
and	O
systemic	O
proinflammatory	O
cytokine	I:C4227660
concentration	I:C4227660
)	O
.	O

In	O
addition	O
,	O
Angeli	O
's	I:C0103301
salt	I:C0103301
decreased	O
the	O
number	O
of	O
Staphylococcus	O
aureus	I:C0038172
colony	B:C0201036
forming	I:C0201036
unities	I:C0201036
in	O
synovial	O
tissue	I:C0224494
,	O
enhanced	O
the	O
bactericidal	O
effect	I:C0544570
of	O
macrophages	O
and	O
inhibited	O
the	O
worsening	O
of	O
systemic	O
inflammatory	I:C0242966
response	I:C0242966
(	O
leukocyte	O
counts	I:C0023508
in	O
the	O
lung	O
and	O
systemic	O
proinflammatory	O
cytokine	I:C4227660
concentration	I:C4227660
)	O
.	O

In	O
addition	O
,	O
Angeli	O
's	I:C0103301
salt	I:C0103301
decreased	O
the	O
number	O
of	O
Staphylococcus	O
aureus	I:C0038172
colony	O
forming	I:C0201036
unities	I:C0201036
in	O
synovial	B:C0224494
tissue	I:C0224494
,	O
enhanced	O
the	O
bactericidal	O
effect	I:C0544570
of	O
macrophages	O
and	O
inhibited	O
the	O
worsening	O
of	O
systemic	O
inflammatory	I:C0242966
response	I:C0242966
(	O
leukocyte	O
counts	I:C0023508
in	O
the	O
lung	O
and	O
systemic	O
proinflammatory	O
cytokine	I:C4227660
concentration	I:C4227660
)	O
.	O

In	O
addition	O
,	O
Angeli	O
's	I:C0103301
salt	I:C0103301
decreased	O
the	O
number	O
of	O
Staphylococcus	O
aureus	I:C0038172
colony	O
forming	I:C0201036
unities	I:C0201036
in	O
synovial	O
tissue	I:C0224494
,	O
enhanced	O
the	O
bactericidal	B:C0544570
effect	I:C0544570
of	O
macrophages	O
and	O
inhibited	O
the	O
worsening	O
of	O
systemic	O
inflammatory	I:C0242966
response	I:C0242966
(	O
leukocyte	O
counts	I:C0023508
in	O
the	O
lung	O
and	O
systemic	O
proinflammatory	O
cytokine	I:C4227660
concentration	I:C4227660
)	O
.	O

In	O
addition	O
,	O
Angeli	O
's	I:C0103301
salt	I:C0103301
decreased	O
the	O
number	O
of	O
Staphylococcus	O
aureus	I:C0038172
colony	O
forming	I:C0201036
unities	I:C0201036
in	O
synovial	O
tissue	I:C0224494
,	O
enhanced	O
the	O
bactericidal	O
effect	I:C0544570
of	O
macrophages	B:C0024432
and	O
inhibited	O
the	O
worsening	O
of	O
systemic	O
inflammatory	I:C0242966
response	I:C0242966
(	O
leukocyte	O
counts	I:C0023508
in	O
the	O
lung	O
and	O
systemic	O
proinflammatory	O
cytokine	I:C4227660
concentration	I:C4227660
)	O
.	O

In	O
addition	O
,	O
Angeli	O
's	I:C0103301
salt	I:C0103301
decreased	O
the	O
number	O
of	O
Staphylococcus	O
aureus	I:C0038172
colony	O
forming	I:C0201036
unities	I:C0201036
in	O
synovial	O
tissue	I:C0224494
,	O
enhanced	O
the	O
bactericidal	O
effect	I:C0544570
of	O
macrophages	O
and	O
inhibited	O
the	O
worsening	B:C1457868
of	O
systemic	O
inflammatory	I:C0242966
response	I:C0242966
(	O
leukocyte	O
counts	I:C0023508
in	O
the	O
lung	O
and	O
systemic	O
proinflammatory	O
cytokine	I:C4227660
concentration	I:C4227660
)	O
.	O

In	O
addition	O
,	O
Angeli	O
's	I:C0103301
salt	I:C0103301
decreased	O
the	O
number	O
of	O
Staphylococcus	O
aureus	I:C0038172
colony	O
forming	I:C0201036
unities	I:C0201036
in	O
synovial	O
tissue	I:C0224494
,	O
enhanced	O
the	O
bactericidal	O
effect	I:C0544570
of	O
macrophages	O
and	O
inhibited	O
the	O
worsening	O
of	O
systemic	B:C0242966
inflammatory	I:C0242966
response	I:C0242966
(	O
leukocyte	O
counts	I:C0023508
in	O
the	O
lung	O
and	O
systemic	O
proinflammatory	O
cytokine	I:C4227660
concentration	I:C4227660
)	O
.	O

In	O
addition	O
,	O
Angeli	O
's	I:C0103301
salt	I:C0103301
decreased	O
the	O
number	O
of	O
Staphylococcus	O
aureus	I:C0038172
colony	O
forming	I:C0201036
unities	I:C0201036
in	O
synovial	O
tissue	I:C0224494
,	O
enhanced	O
the	O
bactericidal	O
effect	I:C0544570
of	O
macrophages	O
and	O
inhibited	O
the	O
worsening	O
of	O
systemic	O
inflammatory	I:C0242966
response	I:C0242966
(	O
leukocyte	B:C0023508
counts	I:C0023508
in	O
the	O
lung	O
and	O
systemic	O
proinflammatory	O
cytokine	I:C4227660
concentration	I:C4227660
)	O
.	O

In	O
addition	O
,	O
Angeli	O
's	I:C0103301
salt	I:C0103301
decreased	O
the	O
number	O
of	O
Staphylococcus	O
aureus	I:C0038172
colony	O
forming	I:C0201036
unities	I:C0201036
in	O
synovial	O
tissue	I:C0224494
,	O
enhanced	O
the	O
bactericidal	O
effect	I:C0544570
of	O
macrophages	O
and	O
inhibited	O
the	O
worsening	O
of	O
systemic	O
inflammatory	I:C0242966
response	I:C0242966
(	O
leukocyte	O
counts	I:C0023508
in	O
the	O
lung	B:C0024109
and	O
systemic	O
proinflammatory	O
cytokine	I:C4227660
concentration	I:C4227660
)	O
.	O

In	O
addition	O
,	O
Angeli	O
's	I:C0103301
salt	I:C0103301
decreased	O
the	O
number	O
of	O
Staphylococcus	O
aureus	I:C0038172
colony	O
forming	I:C0201036
unities	I:C0201036
in	O
synovial	O
tissue	I:C0224494
,	O
enhanced	O
the	O
bactericidal	O
effect	I:C0544570
of	O
macrophages	O
and	O
inhibited	O
the	O
worsening	O
of	O
systemic	O
inflammatory	I:C0242966
response	I:C0242966
(	O
leukocyte	O
counts	I:C0023508
in	O
the	O
lung	O
and	O
systemic	O
proinflammatory	B:C4227660
cytokine	I:C4227660
concentration	I:C4227660
)	O
.	O

Our	O
results	O
suggest	O
for	O
the	O
first	O
time	O
the	O
therapeutic	O
potential	O
of	O
Angeli	B:C0103301
's	I:C0103301
salt	I:C0103301
in	O
a	O
model	O
of	O
septic	O
arthritis	I:C1692886
by	O
mechanisms	O
involving	O
microbicidal	O
effects	I:C1516022
,	O
anti-inflammatory	O
actions	O
and	O
reduction	O
of	O
disease	O
severity	O
.	O

Our	O
results	O
suggest	O
for	O
the	O
first	O
time	O
the	O
therapeutic	O
potential	O
of	O
Angeli	O
's	I:C0103301
salt	I:C0103301
in	O
a	O
model	B:C0684309
of	O
septic	O
arthritis	I:C1692886
by	O
mechanisms	O
involving	O
microbicidal	O
effects	I:C1516022
,	O
anti-inflammatory	O
actions	O
and	O
reduction	O
of	O
disease	O
severity	O
.	O

Our	O
results	O
suggest	O
for	O
the	O
first	O
time	O
the	O
therapeutic	O
potential	O
of	O
Angeli	O
's	I:C0103301
salt	I:C0103301
in	O
a	O
model	O
of	O
septic	B:C1692886
arthritis	I:C1692886
by	O
mechanisms	O
involving	O
microbicidal	O
effects	I:C1516022
,	O
anti-inflammatory	O
actions	O
and	O
reduction	O
of	O
disease	O
severity	O
.	O

Our	O
results	O
suggest	O
for	O
the	O
first	O
time	O
the	O
therapeutic	O
potential	O
of	O
Angeli	O
's	I:C0103301
salt	I:C0103301
in	O
a	O
model	O
of	O
septic	O
arthritis	I:C1692886
by	O
mechanisms	O
involving	O
microbicidal	B:C1516022
effects	I:C1516022
,	O
anti-inflammatory	O
actions	O
and	O
reduction	O
of	O
disease	O
severity	O
.	O

